Related Experiment Videos

[Multi-drug management after myocardial infarct]

H Kritz¹, H Sinzinger

¹Wilhelm-Auerswald Atheroskleroseforschungsgruppe (ASF) Wien.

Wiener Klinische Wochenschrift

|January 1, 1997

Summary

Post-myocardial infarction therapy has evolved with treatments like systemic thrombolysis and angioplasty. Current guidelines recommend early interventions and specific medications, including beta-blockers and ACE-inhibitors, based on patient condition.

Area of Science:

Cardiology
Internal Medicine

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

[Imaging of early carotid artery atherosclerotic lesions with 111In-labeled polyelonalhuman IgG (HIG)].

Nuklearmedizin. Nuclear medicine·2006

Endothelial dysfunction, atherosclerosis and diabetes.

Acta medica Austriaca·2001

6-oxo-PGF(1 alpha)and 8-epi-PGF(2 alpha)in the arterial wall layers of various species: a comparison between intact and atherosclerotic areas.

Prostaglandins, leukotrienes, and essential fatty acids·2001

Association of lipoprotein(a), prostaglandin I(2)--synthesis stimulating plasma factor, biological half-life of prostaglandin I(2)and high-density lipoproteins in HIV-1 infection of different stages.

Prostaglandins, leukotrienes, and essential fatty acids·2000

[Unaltered homocysteine levels during simvastatin therapy].

Wiener klinische Wochenschrift·2000

Semotiadil, a new calcium antagonist, is a very potent inhibitor of LDL-oxidation.

Prostaglandins, leukotrienes, and essential fatty acids·1999

See all related articles